Regulation of tau phosphorylation in microtubule fractions by apolipoprotein E

J Neurosci Res. 1999 May 1;56(3):271-4. doi: 10.1002/(SICI)1097-4547(19990501)56:3<271::AID-JNR6>3.0.CO;2-5.

Abstract

In Alzheimer's disease (AD), a family of proteins collectively named tau are displaced from their normal association with microtubules and are found in in a hyperphosphorylated state deposited into paired helical filaments (PHFs). PHFs are the hallmark cytoskeletal pathology of the disease, and the degree of PHF pathology correlates with the clinical severity of AD. Certain apolipoprotein E (apoE) isoforms have been identified as either risk or protective factors for AD, and one of the proposed mechanisms involves an interaction and potentially modulatory effects on tau hyperphosphorylation by the different apoE isoforms. In these studies, we directly tested the effects of apoE, E2, E3, and E4 on AD-like phosphorylation of tau in brain microtubule fractions. We found that apoE attenuates tau hyperphosphorylation in the fractions, but the pattern was indistinguishable for the different isoforms.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Animals
  • Apolipoproteins A / pharmacology
  • Apolipoproteins E / pharmacology*
  • Blotting, Western
  • Brain
  • Cattle
  • Humans
  • Microtubules / drug effects
  • Microtubules / metabolism*
  • Phosphorylation / drug effects
  • Protein Isoforms / pharmacology
  • Recombinant Proteins / pharmacology
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • tau Proteins / metabolism*

Substances

  • Apolipoproteins A
  • Apolipoproteins E
  • Protein Isoforms
  • Recombinant Proteins
  • tau Proteins
  • Adenosine Triphosphate